Oral antiviral drug effective against respiratory syncytial virus (RSV) identified
Researchers identify cryptic vulnerabilities in an oncoprotein that could be used in novel anti-cancer drugs
24 June 2022Global access to abortion still highly unequal
24 June 2022Oral antiviral drug effective against respiratory syncytial virus (RSV) identified
An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease, according to researchers in the Center for Translational Antiviral Research at Georgia State University.
